{"id":70876,"date":"2026-07-29T18:27:15","date_gmt":"2026-07-29T10:27:15","guid":{"rendered":"https:\/\/flcube.com\/?p=70876"},"modified":"2026-07-29T18:27:16","modified_gmt":"2026-07-29T10:27:16","slug":"tpmeds-secures-tens-of-millions-in-rmb-angel-round-led-by-lotus-lake-ventures-to-advance-tpm004-ind-and-peptetris-platform","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=70876","title":{"rendered":"TPMeds Secures Tens of Millions in RMB Angel Round Led by Lotus Lake Ventures to Advance TPM004 IND and PepTetris Platform"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>TPMeds<\/strong> announced the successful completion of an <strong>Angel financing round<\/strong> amounting to <strong>tens of millions of RMB<\/strong>, with strategic backing from leading Chinese venture capital firms and prominent industry veterans to accelerate development of its ultra-long-acting peptide therapeutics pipeline.<\/p>\n\n\n\n<h2 id=\"h-financing-details\" class=\"wp-block-heading\">Financing Details<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Company<\/strong><\/td><td>TPMeds (private)<\/td><\/tr><tr><td><strong>Round Type<\/strong><\/td><td>Angel financing<\/td><\/tr><tr><td><strong>Amount<\/strong><\/td><td>Tens of millions of RMB<\/td><\/tr><tr><td><strong>Lead Investor<\/strong><\/td><td>Lotus Lake Ventures<\/td><\/tr><tr><td><strong>Participating Investors<\/strong><\/td><td>STAR Capital, Taino Capital, Blue Ocean Capital<\/td><\/tr><tr><td><strong>Strategic Backer<\/strong><\/td><td>Mr. Shen Yousheng (renowned entrepreneur)<\/td><\/tr><tr><td><strong>Announcement Date<\/strong><\/td><td>28 Jul 2026<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-fund-allocation-strategy\" class=\"wp-block-heading\">Fund Allocation Strategy<\/h2>\n\n\n\n<h3 id=\"h-core-pipeline-advancement\" class=\"wp-block-heading\">Core Pipeline Advancement<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Lead Asset:<\/strong> <strong>TPM004<\/strong> \u2013 company&#8217;s core pipeline drug candidate<\/li>\n\n\n\n<li><strong>Primary Objective:<\/strong> Advance <strong>Investigational New Drug (IND) application<\/strong><\/li>\n\n\n\n<li><strong>Clinical Development:<\/strong> Support <strong>Phase I clinical study<\/strong> initiation and execution<\/li>\n\n\n\n<li><strong>Timeline Focus:<\/strong> Accelerate regulatory pathway to first-in-human studies<\/li>\n<\/ul>\n\n\n\n<h3 id=\"h-platform-technology-enhancement\" class=\"wp-block-heading\">Platform Technology Enhancement<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Technology:<\/strong> <strong>PepTetris ultra-long-acting peptide platform<\/strong><\/li>\n\n\n\n<li><strong>Investment Goal:<\/strong> Further enhance platform capabilities and robustness<\/li>\n\n\n\n<li><strong>Strategic Value:<\/strong> Enable continuous innovation across early-stage drug pipeline<\/li>\n\n\n\n<li><strong>Long-term Vision:<\/strong> Establish proprietary platform as foundation for multiple therapeutic candidates<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-investor-consortium-profile\" class=\"wp-block-heading\">Investor Consortium Profile<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The financing brings together a powerful consortium of specialized healthcare investors:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Lotus Lake Ventures:<\/strong> Leading early-stage biotech investor with strong track record in innovative drug development<\/li>\n\n\n\n<li><strong>STAR Capital:<\/strong> Healthcare-focused investment firm with deep regulatory and commercial expertise<\/li>\n\n\n\n<li><strong>Taino Capital:<\/strong> Specialist in breakthrough therapeutic platforms and novel modalities<\/li>\n\n\n\n<li><strong>Blue Ocean Capital:<\/strong> Strategic investor with extensive pharmaceutical industry connections<\/li>\n\n\n\n<li><strong>Mr. Shen Yousheng:<\/strong> Renowned entrepreneur providing strategic guidance and industry mentorship<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">This diverse investor base provides TPMeds with not only capital but also strategic advisory support, regulatory expertise, and potential partnership opportunities.<\/p>\n\n\n\n<h2 id=\"h-market-context-amp-competitive-positioning\" class=\"wp-block-heading\">Market Context &amp; Competitive Positioning<\/h2>\n\n\n\n<h3 id=\"h-ultra-long-acting-peptide-market\" class=\"wp-block-heading\">Ultra-Long-Acting Peptide Market<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Growing Demand:<\/strong> Increasing interest in peptide therapeutics with extended half-lives to improve patient compliance and dosing convenience<\/li>\n\n\n\n<li><strong>Technology Differentiation:<\/strong> PepTetris platform positions TPMeds to compete in the rapidly evolving long-acting biologics space<\/li>\n\n\n\n<li><strong>Therapeutic Potential:<\/strong> Ultra-long-acting peptides offer advantages over traditional small molecules and standard biologics in specific disease areas<\/li>\n<\/ul>\n\n\n\n<h3 id=\"h-early-stage-biotech-landscape\" class=\"wp-block-heading\">Early-Stage Biotech Landscape<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Funding Environment:<\/strong> Despite challenging market conditions, high-quality early-stage biotech companies with novel platforms continue to attract strategic investment<\/li>\n\n\n\n<li><strong>China Innovation Ecosystem:<\/strong> Strong government support for domestic innovative drug development creates favorable environment for platform-based biotech companies<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward-looking statements regarding financing use, clinical development timelines, and platform advancement. Actual results may differ due to regulatory decisions, clinical trial outcomes, and market conditions.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>TPMeds announced the successful completion of an Angel financing round amounting to tens of millions&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,10],"tags":[4872],"class_list":["post-70876","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-tpmeds"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>TPMeds Secures Tens of Millions in RMB Angel Round Led by Lotus Lake Ventures to Advance TPM004 IND and PepTetris Platform - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"TPMeds announced the successful completion of an Angel financing round amounting to tens of millions of RMB, with strategic backing from leading Chinese venture capital firms and prominent industry veterans to accelerate development of its ultra-long-acting peptide therapeutics pipeline.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=70876\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TPMeds Secures Tens of Millions in RMB Angel Round Led by Lotus Lake Ventures to Advance TPM004 IND and PepTetris Platform\" \/>\n<meta property=\"og:description\" content=\"TPMeds announced the successful completion of an Angel financing round amounting to tens of millions of RMB, with strategic backing from leading Chinese venture capital firms and prominent industry veterans to accelerate development of its ultra-long-acting peptide therapeutics pipeline.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=70876\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-29T10:27:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-29T10:27:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=70876#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=70876\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"TPMeds Secures Tens of Millions in RMB Angel Round Led by Lotus Lake Ventures to Advance TPM004 IND and PepTetris Platform\",\"datePublished\":\"2026-07-29T10:27:15+00:00\",\"dateModified\":\"2026-07-29T10:27:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=70876\"},\"wordCount\":401,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"TPMeds\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=70876#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=70876\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=70876\",\"name\":\"TPMeds Secures Tens of Millions in RMB Angel Round Led by Lotus Lake Ventures to Advance TPM004 IND and PepTetris Platform - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-07-29T10:27:15+00:00\",\"dateModified\":\"2026-07-29T10:27:16+00:00\",\"description\":\"TPMeds announced the successful completion of an Angel financing round amounting to tens of millions of RMB, with strategic backing from leading Chinese venture capital firms and prominent industry veterans to accelerate development of its ultra-long-acting peptide therapeutics pipeline.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=70876#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=70876\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=70876#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TPMeds Secures Tens of Millions in RMB Angel Round Led by Lotus Lake Ventures to Advance TPM004 IND and PepTetris Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"TPMeds Secures Tens of Millions in RMB Angel Round Led by Lotus Lake Ventures to Advance TPM004 IND and PepTetris Platform - Insight, China&#039;s Pharmaceutical Industry","description":"TPMeds announced the successful completion of an Angel financing round amounting to tens of millions of RMB, with strategic backing from leading Chinese venture capital firms and prominent industry veterans to accelerate development of its ultra-long-acting peptide therapeutics pipeline.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=70876","og_locale":"en_US","og_type":"article","og_title":"TPMeds Secures Tens of Millions in RMB Angel Round Led by Lotus Lake Ventures to Advance TPM004 IND and PepTetris Platform","og_description":"TPMeds announced the successful completion of an Angel financing round amounting to tens of millions of RMB, with strategic backing from leading Chinese venture capital firms and prominent industry veterans to accelerate development of its ultra-long-acting peptide therapeutics pipeline.","og_url":"https:\/\/flcube.com\/?p=70876","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-07-29T10:27:15+00:00","article_modified_time":"2026-07-29T10:27:16+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=70876#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=70876"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"TPMeds Secures Tens of Millions in RMB Angel Round Led by Lotus Lake Ventures to Advance TPM004 IND and PepTetris Platform","datePublished":"2026-07-29T10:27:15+00:00","dateModified":"2026-07-29T10:27:16+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=70876"},"wordCount":401,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["TPMeds"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=70876#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=70876","url":"https:\/\/flcube.com\/?p=70876","name":"TPMeds Secures Tens of Millions in RMB Angel Round Led by Lotus Lake Ventures to Advance TPM004 IND and PepTetris Platform - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-07-29T10:27:15+00:00","dateModified":"2026-07-29T10:27:16+00:00","description":"TPMeds announced the successful completion of an Angel financing round amounting to tens of millions of RMB, with strategic backing from leading Chinese venture capital firms and prominent industry veterans to accelerate development of its ultra-long-acting peptide therapeutics pipeline.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=70876#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=70876"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=70876#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"TPMeds Secures Tens of Millions in RMB Angel Round Led by Lotus Lake Ventures to Advance TPM004 IND and PepTetris Platform"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/70876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=70876"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/70876\/revisions"}],"predecessor-version":[{"id":70877,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/70876\/revisions\/70877"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=70876"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=70876"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=70876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}